NextPlat Corp (NASDAQ: NXPL, NXPLW) has announced an agreement to acquire an independent pharmacy in a rural community near Pensacola, Florida, for $1.5 million in cash, with the transaction expected to close during the fourth quarter of 2026, subject to customary closing conditions. The acquisition will expand the company’s PharmcoRx retail footprint into an underserved market, where it plans to introduce same-day delivery, online fulfillment and higher-margin contracted services, including support for healthcare providers participating in the federal 340B Drug Pricing Program, long-term care facilities and government agencies.
The pharmacy generated approximately $5.6 million in sales during 2025 with retail margins of about 19% and operated profitably with positive working capital and no debt. NextPlat said the acquisition supports its strategy of expanding healthcare operations through rural pharmacy acquisitions, building on PharmcoRx’s existing network of four specialty pharmacies in Florida and the healthcare segment’s $39.7 million contribution to the company’s $54.3 million in 2025 revenue. The deal underscores NextPlat’s focus on high-margin healthcare services, particularly the 340B program, which allows eligible healthcare organizations to purchase outpatient drugs at significantly reduced prices.
This acquisition is important because it highlights NextPlat’s strategic pivot toward healthcare services, which now account for the majority of its revenue. By targeting rural and underserved areas, the company is addressing a critical gap in pharmacy access while capitalizing on federal programs that offer stable, recurring revenue streams. The move also demonstrates how small, profitable independent pharmacies can be attractive acquisition targets for larger firms seeking to scale operations efficiently.
For more details, the full press release is available at https://nnw.fm/8bVkW. Additional information about NextPlat Corp can be found in the company’s newsroom at https://nnw.fm/NXPL.
